Initiator Pharma A/S Stock Forecast for 2023 - 2025 - 2030

Updated on 04/26/2024

Stock Rating
0
Price Target
kr16.48
Consensus
Upside
84.34%
Analysts
0
Stock Rating
0
Upside
84.34%
Analysts
0
Price Target
kr16.48

Initiator Pharma A/S Stock Forecast and Price Target

The average price target for Initiator Pharma A/S's stock set by recognized analysts recently is kr16.48, which would result in a potential upside of approximately 84.34% if it reached this mark. The estimation is based on a high estimate of kr16.94 and a low estimate of kr16.02.

kr16.48

84.34% Upside

Initiator Pharma A/S Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Initiator Pharma A/S's Price has grown, increasing from kr0.00 to kr0.00 – a growth of 100.00%. The next year looks promising for Initiator Pharma A/S, with analysts predicting Fair Value of kr0.00 – an increase of 100.00%. Over the next six years, experts anticipate that Initiator Pharma A/S's Fair Value will grow at a rate of 100.00%.

2025 Fair Value Forecast
kr0.00
2026 Fair Value Forecast
kr0.00
2027 Fair Value Forecast
kr0.00
2028 Fair Value Forecast
kr0.00
2029 Fair Value Forecast
kr0.00
2030 Fair Value Forecast
kr0.00

Initiator Pharma A/S Revenue Forecast for 2023 - 2025 - 2030

Initiator Pharma A/S Dividend per Share Forecast for 2023 - 2025 - 2030

Initiator Pharma A/S Free Cash Flow Forecast for 2023 - 2025 - 2030

Initiator Pharma A/S EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Initiator Pharma A/S's EBITDA has grown by 297.05%, rising from kr-10.51M to kr-41.73M. In the following year, 0 experts forecast Initiator Pharma A/S's EBITDA will decrease by 47.97%, to kr-21.71M. In 2030, professionals predict that Initiator Pharma A/S's EBITDA will decrease by 34.08%, to kr-27.51M.

2023 EBITDA Forecast
kr-21713510.00
2024 EBITDA Forecast
kr-21208309.00
2025 EBITDA Forecast
kr-24730302.18
2026 EBITDA Forecast
kr-31351428.42
2027 EBITDA Forecast
kr-27904861.39
2028 EBITDA Forecast
kr-25764558.52
2029 EBITDA Forecast
kr-25725052.86
2030 EBITDA Forecast
kr-27509514.03

Initiator Pharma A/S EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Initiator Pharma A/S's EBIT has grown by 296.39%, rising from kr-10.53M to kr-41.74M. According to 0 major analysts, Initiator Pharma A/S's EBIT will fall by 47.94% in the next year, reaching kr-21.73M. Professionals believe that By 2030, Initiator Pharma A/S's EBIT will fall to kr-27.52M– a 34.07% decrease from its current value.

2023 EBIT Forecast
kr-21729844.00
2024 EBIT Forecast
kr-21222814.31
2025 EBIT Forecast
kr-24742264.35
2026 EBIT Forecast
kr-31361644.80
2027 EBIT Forecast
kr-27918136.20
2028 EBIT Forecast
kr-25777745.76
2029 EBIT Forecast
kr-25736501.37
2030 EBIT Forecast
kr-27520040.91

Initiator Pharma A/S EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Initiator Pharma A/S's EPS has grown, increasing from kr-0.32 to kr0.00 – a growth of 100.00%. The next year looks promising for Initiator Pharma A/S, with analysts predicting EPS of kr0.00 – an increase of 100.00%. Over the next six years, experts anticipate that Initiator Pharma A/S's EPS will grow at a rate of 100.00%.

2025 EPS Forecast
kr0.00
2026 EPS Forecast
kr0.00
2027 EPS Forecast
kr0.00
2028 EPS Forecast
kr0.00
2029 EPS Forecast
kr0.00
2030 EPS Forecast
kr0.00